title: Influence of sesamin on CYP2C-mediated diclofenac metabolism: in vitro and in vivo analysis.
abstract: Our previous studies revealed that sesamin caused a mechanism-based inhibition (MBI) of CYP2C9 in human liver microsomes. Additionally, we observed a similar MBI of CYP2C by sesamin in the rat liver microsomes. Sesamin-induced difference spectra of rat or human liver microsomes in the presence of NADPH showed a peak at 459 nm, suggesting the formation of a metabolic-intermediate (MI) complex of cytochrome P450 and the methylenedioxyphenyl group of sesamin. However, the peak disappeared in both liver microsomes within 30 min after the termination of the metabolism. These results suggest that the MI complex of cytochrome P450 and sesamin is unstable, and the effects of sesamin on human CYP2C9- or rat CYP2C-mediated drug metabolism may be small. To confirm this, in vivo studies using rats were performed. The pharmacokinetics of diclofenac, which is mainly metabolized by CYP2C11 in male rats, were investigated after a 3-days administration of sesamin (0, 10, and 100 mg/kg bw). No significant differences were observed among the three groups in the pharmacokinetic parameters, C max, T max, and AUC. Furthermore, administration of sesamin to rats for 7 days had no significant effects on diclofenac hydroxylation activity in rat liver microsomes. These results demonstrate that no significant interaction occurs between diclofenac and sesamin in rats. Moreover, the results of these in vitro and in vivo studies suggest that no significant interaction may occur between sesamin and diclofenac when sesamin is administered to humans as a supplement, since the standard sesamin dose in humans is much lower than that administered to rats in this study.
authors.affiliation: Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.
authors.forename: Kaori
authors.initials: K
authors.lastname: Yasuda
authors.affiliation: Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.
authors.forename: Sera
authors.initials: S
authors.lastname: Ueno
authors.affiliation: Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.
authors.forename: Erika
authors.initials: E
authors.lastname: Ueda
authors.affiliation: Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.
authors.forename: Miyu
authors.initials: M
authors.lastname: Nishikawa
authors.affiliation: Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.
authors.forename: Kie
authors.initials: K
authors.lastname: Takeda
authors.affiliation: Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.
authors.forename: Masaki
authors.initials: M
authors.lastname: Kamakura
authors.affiliation: Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.
authors.forename: Shinichi
authors.initials: S
authors.lastname: Ikushiro
authors.affiliation: Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Sakaki
keywords: CYP2C; cytochrome P450; diclofenac; mechanism-based inhibition; metabolism; sesamin.